End users who will benefit from attending include CXOs, EVPs, SVPs, VPs, Executive Directors, Directors and Global Heads responsible for:
Cell and Gene Manufacturing
Gene Therapy | Cell Therapy
Cell Line Development
Quality Over Quantity
Technical Operations and Manufacturing
Investigational Material Supply Chain
Product Research and Development
Stem Cell Manufacturing
Novel Vector Systems
4th Annual Cell & Gene Therapy Innovation Leaders Summit 2022
Visualising The Future
“The Global Cell and Gene Therapy Market is estimated to be worth between £10 to £40 Billion by 2025”
The Annual Cell and Gene Therapy Innovation Summit is the only executive gathering committed to creating an advanced networking platform to increase innovation and collaboration within the Cell & Gene Therapy area.
Our cutting-edge programme covers critical subjects such as progress cell gene therapy manufacturing, ATMP development, scale-up and scale-out, manufacturing data, R&D, CAR-T therapies, global regulatory affairs, stem cells, cord blood, pricing & reimbursement, improving cost efficiency, commercialization, as well how to leverage innovation to convert cutting-edge research to advance cell gene therapy manufacturing.